TECHNETIUM TC-99M TROFOLASTAT CHLORIDE
drug drugOn this page
Also known as 99mtc-mip-1404Cloruro de tecnecio (99mtc) trofolastatF-1311MIP TC-1404MIP-99MTC-1404Technetium (99mtc) trofolastat chlorideTechnetium tc 99m trofolastat chloride
Summary
Technetium Tc-99M Trofolastat Chloride (CHEMBL4297855) is a phase-3 clinical-stage unknown (ATC V09IA10).
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- ATC class: V09IA10
- Clinical trials: 4
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL4297855 |
| Name | TECHNETIUM TC-99M TROFOLASTAT CHLORIDE |
| Type | Unknown |
| Max phase | 3 |
| ATC | V09IA10 |
Also known as: 99mtc-mip-1404, Cloruro de tecnecio (99mtc) trofolastat, F-1311, MIP TC-1404, MIP-99MTC-1404, Technetium (99mtc) trofolastat chloride, Technetium tc 99m trofolastat chloride, Technetium tc-99m trofolastat chloride, TECHNETIUM TC-99M TROFOLASTAT CHLORIDE
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.
Clinical trials
Total trials: 4.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE1 | 2 |
| PHASE3 | 1 |
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02615067 | PHASE3 | COMPLETED | Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer |
| NCT01667536 | PHASE2 | COMPLETED | A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology |
| NCT01572701 | PHASE1 | COMPLETED | Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection |
| NCT01654874 | PHASE1 | COMPLETED | 99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404 |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.